Business - Briefly   

Organon India pact with Glaxo SmithKline

CHENNAI: Organon India has established a co-marketing arrangement with Glaxo SmithKline Pharmaceuticals India for two of its oral contraceptive pills — Femilon and Cerazette. The company, which is a part of the pharmaceutical business unit of Akzo Nobel, has also recently launched the `Let's Talk' educational programme together with the Federation of Obstetrics and Gynaecological Societies of India (FOGSI) and has in place a toll free helpline `Let's Talk' (1600-22-1400), says a company release.

Printer friendly page  
Send this article to Friends by E-Mail

Business

News: Front Page | National | Tamil Nadu | Andhra Pradesh | Karnataka | Kerala | New Delhi | Other States | International | Opinion | Business | Sport | Miscellaneous | Engagements |
Advts: Classifieds | Employment | Obituary | Updates: Breaking News |

Stories in this Section

China eases cap on investment abroad
12 States heading for power crisis
40 p.c. jump in oil bill
Apollo Hospitals net up 33 p.c.
`Allow repatriation to boost FDI in real estate'
Tata International forays into China
Jet launches London service
4 million new jobs projected in housing sector: Assocham
New SAT members appointed
Sensex extends gains
Exchange rates
Bullion rates
El Forge to buy stake in U.K. firm
Central Bank launches Gold Card to exporters
Bank of Baroda pays 32 p.c. final
Organon India pact with Glaxo SmithKline
Super Spinning Mills pays 40 p.c.
Ma Foi sets up office in Allahabad
Air India invites EoIs
C. P. Singh re-elected Kribhco chief
i-flex in alliance with Castek Software
Satyam joins Microsoft initiative

Copyright © 2005, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu